Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Mevo Health vs Teladoc Health

Mevo Health
Graded #326

Higher grade

vs+4.300000000000004
Teladoc Health
Graded #428

Lower grade

The verdict

Mevo Health takes it — 60.2/100 to 55.9/100.

Mevo Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mevo Health (Mevo Health LLC, Delaware) is a direct-pay telehealth platform offering compounded semaglutide and tirzepatide in both injection and oral-tablet forms — a rare both-routes, both-molecules menu.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMevo Health +11
56
45
Dose & formulationMevo Health +43
83
40
Clinical oversightTeladoc Health +10
67
77
Labs & monitoringTeladoc Health +9
52
61
FulfillmentTeladoc Health +7
57
64
Contract termsTeladoc Health +35
20
55
Mevo Health · left barTeladoc Health · right bar

The numbers

MetricMevo HealthTeladoc Health
WeighScore60.2/10055.9/100
GradeCC
Scorecard rank#326#428
Semaglutide$199/mo (all doses, compounded)Not disclosed
Tirzepatide$259/mo (all doses, compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Mevo Health

Graded #326 · C

Strengths

  • LegitScript verification badge on multiple pages
  • Publishes the FDA compounded-medication disclaimer
  • Four named board-certified physicians disclosed (Wasef, Suppa, Sakla, Chikando)
  • Both semaglutide and tirzepatide in injection and oral-tablet forms — rare in DTC
  • Public entry-level pricing surfaced

Where it loses points

  • States served not listed on any public page
  • Pharmacy partners not named (only '503A U.S. compounding pharmacies' with unlabeled logos)
  • No formal Medical Director role disclosed
  • Only 'as low as' entry pricing shown — no per-dose itemization
  • No SOC 2 certification claimed
Teladoc Health

Graded #428 · C

Strengths

  • Dedicated GLP-1 Prescription and Support program for weight management
  • Backed by one of the largest virtual care companies in the US
  • Partners with 50%-plus of Fortune 500 and 100-plus health plans
  • Adds nutrition, coaching and connected device tracking
  • Strong clinical credibility and brand trust

Where it loses points

  • Distributed mainly via employers and health plans, limited direct cash-pay
  • No transparent published monthly price for GLP-1 care
  • Specific medications and eligibility vary by plan coverage
  • Member experience can depend on the employer's chosen configuration

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard